Drugs
This week, The Humungus is buying biotech. Now, biotech isn't for everybody; it's volatile, speculative, there's no dividends and little profit in the beginning. But, it's been smacked down recently - see IBB https://www.google.com/finance?chdnp=1&chdd=1&chds=1&chdv=1&chvs=maximized&chdeh=0&chfdeh=0&chdet=1396392380890&chddm=85789&chls=IntervalBasedLine&q=NASDAQ:IBB&ntsp=0&ei=q0E7U-CzDoyxqAGefQ
But, the good news is that when biotech goes up - she flies baby. Now, The Humungus is buying specific biotech stocks this week, not the ETF, but rather than be accused of pump and dump (that's a stock scam term not a techno term), I'll be purposely vague.
And by the way, when it comes to months, statistically speaking, April is the good month. She delivers 2% on average; ain't she sweet?
Remember, when it comes to drugs: "In this country, you gotta make the money first. Then when you get the money, you get the power. Then when you get the power, then you get the women."
But, the good news is that when biotech goes up - she flies baby. Now, The Humungus is buying specific biotech stocks this week, not the ETF, but rather than be accused of pump and dump (that's a stock scam term not a techno term), I'll be purposely vague.
And by the way, when it comes to months, statistically speaking, April is the good month. She delivers 2% on average; ain't she sweet?
Remember, when it comes to drugs: "In this country, you gotta make the money first. Then when you get the money, you get the power. Then when you get the power, then you get the women."
Comments
Post a Comment